Colossal Biosciences, a Texas startup founded in 2021, has made a significant advancement in its efforts to bring back the dodo bird through de-extinction.
▶ LISTEN TO ORLANDO’S MORNING NEWS EXPRESS PODCAST ON WDBO
The company successfully cultivated primordial germ cells from pigeons, a key step in the process.
Colossal plans to use gene-edited surrogates, such as chickens injected with Nicobar pigeon cells, to eventually breed dodos.
READ: M&M’s maker turns to gene editing to try to secure cocoa supply
The company aims to reintroduce thousands of genetically diverse dodos into rat-free areas of Mauritius, where the birds were last seen in 1662.
Despite criticism from some biologists, Colossal has raised $120 million in funding and is valued at $10.3 billion.
As Colossal trumpets on Facebook, “the path to dodo de-extinction has been forged.”
Click here to download our free news, weather and traffic app. And click here to subscribe to our daily 3 Big Things newsletter.